Literature DB >> 8892363

Add-on therapy of fenfluramine in intractable self-induced epilepsy.

M Boel1, P Casaer.   

Abstract

Eleven institutionalized children (7 girls, 4 boys) with refractory epilepsy received fenfluramine as add-on therapy. Besides therapy resistance, the patients manifested self-induction of seizures. Eight patients were photosensitive and/or pattern sensitive. All antiepileptic drugs of doubtful efficacy were withdrawn. During withdrawal, patients did neither improve nor show an increase in seizure frequency. Fenfluramine was then added and administered once to three times daily at dosages between 0.5 and 1 mg/kg.day. Side effects were mild and transient. Of the 11 patients, 7 became seizure-free and in 4 patients a more than 75% decrease of all seizures was obtained.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8892363     DOI: 10.1055/s-2007-973781

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  12 in total

Review 1.  Treatment Strategies for Dravet Syndrome.

Authors:  Kelly G Knupp; Elaine C Wirrell
Journal:  CNS Drugs       Date:  2018-04       Impact factor: 5.749

Review 2.  Pharmacotherapy for Dravet Syndrome.

Authors:  Adam Wallace; Elaine Wirrell; Daniel L Kenney-Jung
Journal:  Paediatr Drugs       Date:  2016-06       Impact factor: 3.022

Review 3.  Photo-Dependent Reflex Seizures-A Scoping Review with Proposal of Classification.

Authors:  Jolanta Strzelecka; Dariusz Wojciech Mazurkiewicz; Tymon Skadorwa; Jakub S Gąsior; Sergiusz Jóźwiak
Journal:  J Clin Med       Date:  2022-06-29       Impact factor: 4.964

4.  Clinical and electrographic features of sunflower syndrome.

Authors:  Fiona M Baumer; Brenda E Porter
Journal:  Epilepsy Res       Date:  2018-03-03       Impact factor: 3.045

Review 5.  Recent Advances in the Drug Treatment of Dravet Syndrome.

Authors:  Elaine C Wirrell; Rima Nabbout
Journal:  CNS Drugs       Date:  2019-09       Impact factor: 5.749

Review 6.  Low-dose fenfluramine in the treatment of neurologic disorders: experience in Dravet syndrome.

Authors:  An-Sofie Schoonjans; Lieven Lagae; Berten Ceulemans
Journal:  Ther Adv Neurol Disord       Date:  2015-11       Impact factor: 6.570

Review 7.  Serotonergic therapy in epilepsy.

Authors:  Frank G Gilliam; Hrvoje Hecimovic; Matthew S Gentry
Journal:  Curr Opin Neurol       Date:  2021-04-01       Impact factor: 5.710

8.  Large-Scale Phenotype-Based Antiepileptic Drug Screening in a Zebrafish Model of Dravet Syndrome

Authors:  Matthew T Dinday; Scott C Baraban
Journal:  eNeuro       Date:  2015-08-31

Review 9.  Targeted Treatment in Childhood Epilepsy Syndromes.

Authors:  Katharina Vezyroglou; J Helen Cross
Journal:  Curr Treat Options Neurol       Date:  2016-06       Impact factor: 3.598

10.  Low-dose fenfluramine significantly reduces seizure frequency in Dravet syndrome: a prospective study of a new cohort of patients.

Authors:  A Schoonjans; B P Paelinck; F Marchau; B Gunning; A Gammaitoni; B S Galer; L Lagae; B Ceulemans
Journal:  Eur J Neurol       Date:  2016-10-28       Impact factor: 6.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.